We are monitoring the impact of COVID-19 & Recession alarm on Latin America Precision Medicine Market Get in touch with us for detailed analysis Know More
Share on

Latin America Precision Medicine Market Research Report – Segmented By Technology, Application, By Country (Brazil, Argentina, Mexico, Chile and Rest of Latin America) - Size, Share, Trends, Growth Opportunities Assessment, Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 1402
Pages: 145

Latin America Precision Medicine Market Size (2022 to 2027)

The size of the Latin America Precision Medicine Market is projected to be growing at a CAGR of 5.66% during the forecast period. The market is forecasted to be worth USD 10.11 billion by 2027 from USD 5.66 billion in 2022.

Precision medicine is one of the greatest opportunities for new medical breakthroughs. It is a combination of molecular biology techniques and systems biology. Oncology is the initial area of focus for precision medicine, as cancer is one of the leading causes of death worldwide, and its incidence is increasing as the population ages.

The precision medicine market in the Latin American region is expected to be majorly driven by big data analytics. Also, with the using technology such as next-generation sequencing (NGS), data analytics, and so on, pharmaceutical and biotech businesses are likely to dominate the market during the projected period. The other factors, such as the favorable government laws and regulations for personalized medicine and increasing awareness about precision medicine, are expected to propel the market growth.

Additionally, advancements in drug discovery technology, next-generation sequencing, and companion diagnostics are projected to promote market growth. The countries such as Brazil and Mexico are focussing on personalized treatment and procedures. Brazil is anticipated to become one of the region's major pharma producers, owing to a rising focus on creating cost-effective diagnostic tools for precision medicine.

Furthermore, increasing investments by the government and private organizations in diagnostics research and development activities are expected to encourage market growth. Furthermore, precision medicine is gaining popularity among the general public due to the development of personal medical devices and intelligent approaches into the healthcare system. Furthermore, the precision medicine industry's continuous expansion is aided by expanding collaborations among different ecosystem participants.

Moreover, the major players in the market are implementing various strategies to gain a competitive advantage over the other market participants. The strategies include partnerships, mergers, and acquisitions for accessing advanced medical equipment and healthcare IT solutions to increase market growth. In addition, the Brazilian Initiative on Precision Medicine is a collaboration between several research institutes and dissemination centers in Brazil. Such measures are likely to bolster the precision medicine market's growth.

In Latin American countries such as Mexico and Brazil, public healthcare spending is inadequate. As a result, the adoption of precision medicine and enhanced healthcare assistance necessitates high out-of-pocket costs, which may impede market expansion. Furthermore, about 31% of the Latin American population cannot receive healthcare due to financial constraints. Therefore, precision medicine development and application can be difficult in such conditions.

This research report on the Latin American Precision Medicine Market has been segmented and sub-segmented into the following categories:

By Technology: 

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Others

By Application: 

  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Others

By Country: 

  • Brazil
  • Argentina
  • Mexico
  • Chile
  • Rest of Latin America

Geographically, in Brazil, precision medicine is at the beginning stage. However, medical research epidemiology and clinical practice have steadily incorporated genomic science and technology, especially in oncology. With the help of the Sao Paulo State Research Foundation (FAPESP), the Brazilian government took the initiative for precision medicine. It was launched in Sao Paulo, which combines five research, innovation, and diffusion centers (CEPIDs). This initiative was to implement precision medicine in Brazil. The private lab in Brazil offers personalized medicine on its website. A rise in awareness over the availability of different treatment procedures is escalating the market's growth rate. 

Mexico is one of the first adopters of genomic and personalized medicine from the latest phase of the human genome project. The National Institute of Genomic Medicine (INMEGEN) collaborative initiative has been working on genome sequencing. Constant economic growth is also one of the factors for the market to grow in this country. 

KEY MARKET PLAYERS:

A few of the prominent companies in the Latin America precision medicine market are Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Technology                

                                5.1.1 Introduction           

                                5.1.2 Big Data Analytics

                                5.1.3 Bioinformatics       

                                5.1.4 Gene Sequencing

                                5.1.5 Drug Discovery      

                                5.1.6 Companion Diagnostics     

                                5.1.7 Others      

                                5.1.8 Y-o-Y Growth Analysis, By Technology         

                                5.1.9 Market Attractiveness Analysis, By Technology       

                                5.1.10 Market Share Analysis, By Technology      

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Oncology 

                                5.2.3 CNS            

                                5.2.4 Immunology          

                                5.2.5 Respiratory             

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Application         

                                5.2.8 Market Attractiveness Analysis, By Application        

                                5.2.9 Market Share Analysis, By Application         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Type

                                                6.1.3.4 By Application

                                                6.1.3.5 By Indication

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Type

                                                6.1.4.4 By Application

                                                6.1.4.5 By Indication

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Type

                                                6.1.5.4 By Application

                                                6.1.5.5 By Indication

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Pfizer                            

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Roche                           

                8.3 Covance                      

                8.4 Novartis                       

                8.5 Qiagen                         

                8.6 Biocrates Life Sciences                          

                8.7 Teva Pharmaceutical                              

                8.8 Nanostring Technologies                      

                8.9 Laboratory Corporation of America Holdings                

                8.10 Medtronic                

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Latin America Precision Medicine Market, By Region, From 2022 - 2027 (USD Billion)
  2. Latin America Precision Medicine Market, By Technology, From 2022 - 2027 (USD Billion)
  3. Latin America Big Data Analytics Market, By Region, From 2022 - 2027 (USD Billion)
  4. Latin America Bioinformatics Market, By Region, From 2022 - 2027 (USD Billion)
  5. Latin America Gene Sequencing Market, By Region, From 2022 - 2027 (USD Billion)
  6. Latin America Drug Discovery Market, By Region, From 2022 - 2027 (USD Billion)
  7. Latin America Companion Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  8. Latin America Other Precision Medicine Technologies Market, By Region, From 2022 - 2027 (USD Billion)
  9. Latin America Precision Medicine Market, By Application, From 2022 - 2027 (USD Billion)
  10. Latin America Oncology Precision Medicine Market, By Region, From 2022 - 2027 (USD Billion)
  11. Latin America CNS Precision Medicine Market, By Region, From 2022 - 2027 (USD Billion)
  12. Latin America Immunology Precision Medicine Market, By Region, From 2022 - 2027 (USD Billion)
  13. Latin America Respiratory Precision Medicine Market, By Region, From 2022 - 2027 (USD Billion)
  14. Latin America Other Precision Medicine Applications Market, By Region, From 2022 - 2027 (USD Billion)
  15. Brazil Precision Medicine Market, By Technology, From 2022 - 2027 (USD Billion)
  16. Brazil Precision Medicine Market, By Application, From 2022 - 2027 (USD Billion)
  17. Argentina Precision Medicine Market, By Technology, From 2022 - 2027 (USD Billion)
  18. Argentina Precision Medicine Market, By Application, From 2022 - 2027 (USD Billion)
  19. Mexico Precision Medicine Market, By Technology, From 2022 - 2027 (USD Billion)
  20. Mexico Precision Medicine Market, By Application, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample